newsfilter
← Latest News
GlobeNewswire·

Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma’s Acquisition of Arvelle Therapeutics

Company to receive up to $20 million in upfront and milestone payments from non-dilutive transactionTransaction extends cash runway into 2022 NEW YORK, N.Y. and RESEARCH TRIANGLE PARK, N.C., Jan. ...